Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

20025,409 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 359, Issue 9311, pp. 995-1003

Field-Weighted Citation Impact: 297.00